From HIMSS: As we all continue to navigate the COVID-19 pandemic, the health and safety of the global HIMSS community, employees and local residents remain our top priority. That’s why we’re moving HIMSS21 to August 9–13, 2021 in Las Vegas.
Read More
The Sequoia Project launched new resources and training for the healthcare and health IT communities preparing for the November 2, 2020 deadline to comply with U.S. Office of the National Coordinator for Health IT information blocking and interoperability rules.
Twenty-three of the nation’s leading healthcare experts gathered virtually recently, marking the first of several Taskforce on Telehealth Policy deliberations set to run through late August.
A new report from the U.C. Berkeley Labor Center and Working Partnerships USA released shows how technology is likely to impact job quality in healthcare and suggests that technological adoption may accelerate as a result of the COVID-19 pandemic.
The Health Care business of LexisNexis® Risk Solutions announced the results of its annual focus group, comprised of over 20 healthcare IT executives that are members of the College of Healthcare Information Management Executives (CHIME).
EHNAC announced that it has posted a new version of program criteria for public review. The open process for adopting criteria will commence on July 15 and end on September 4.
DrFirst, a healthcare technology pioneer, is urging the Drug Enforcement Administration (DEA) to change its rules for electronic prescribing of controlled substances (EPCS) in comments submitted to the agency on June 22.
National increase from 0.15 percent of medical claim lines in April 2019 to 13.00 percent in April 2020, according to new data from FAIR Health’s Monthly Telehealth Regional Tracker. The data represent the privately insured population, excluding Medicare and Medicaid.
The National Institute of Allergy and Infectious Diseases established new clinical trials network aiming to enroll thousands of volunteers in large-scale clinical trials testing vaccines and monoclonal antibodies intended to protect people from COVID-19.